Warning: The NCBI web site requires JavaScript to function. more...
Urokinase-type plasminogen activator and arthritis progression: role in systemic disease with immune complex involvement.
Cook AD, De Nardo CM, Braine EL, Turner AL, Vlahos R, Way KJ, Beckman SK, Lenzo JC, Hamilton JA.
Arthritis Res Ther. 2010;12(2):R37. Epub 2010 Mar 2.
Related citations
Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.
Arthritis Res. 1999;1(1):81-91. Epub 1999 Oct 26.
Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritis.
Cook AD, Braine EL, Campbell IK, Hamilton JA.
Am J Pathol. 2002 Mar;160(3):917-26.
Urokinase-type plasminogen activator and arthritis progression: contrasting roles in systemic and monoarticular arthritis models.
De Nardo CM, Lenzo JC, Pobjoy J, Hamilton JA, Cook AD.
Arthritis Res Ther. 2010;12(5):R199. Epub 2010 Oct 25.
Tissue-type plasminogen activator deficiency exacerbates arthritis.
Yang YH, Carmeliet P, Hamilton JA.
J Immunol. 2001 Jul 15;167(2):1047-52.
The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation.
Cook AD, Vlahos R, Massa CM, Braine EL, Lenzo JC, Turner AL, Way KJ, Hamilton JA.
Thromb Haemost. 2006 Apr;95(4):659-67.
Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in mice.
Levi M, Moons L, Bouché A, Shapiro SD, Collen D, Carmeliet P.
Circulation. 2001 Apr 17;103(15):2014-20.
The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis.
Li J, Ny A, Leonardsson G, Nandakumar KS, Holmdahl R, Ny T.
Am J Pathol. 2005 Mar;166(3):783-92.
Tissue-type plasminogen activator depletion affects the nasal mucosa matrix reconstruction in allergic rhinitis mice.
Hua H, Zhang R, Yu S, Wang H, Zhao Y, Yu S, Li W.
Allergol Immunopathol (Madr). 2011 Jul-Aug;39(4):206-11. Epub 2011 Feb 19.
Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
Ito Y, Usui T, Kobayashi S, Iguchi-Hashimoto M, Ito H, Yoshitomi H, Nakamura T, Shimizu M, Kawabata D, Yukawa N, Hashimoto M, Sakaguchi N, Sakaguchi S, Yoshifuji H, Nojima T, Ohmura K, Fujii T, Mimori T.
Arthritis Rheum. 2009 Aug;60(8):2294-303.
Regulation of systemic and local myeloid cell subpopulations by bone marrow cell-derived granulocyte-macrophage colony-stimulating factor in experimental inflammatory arthritis.
Cook AD, Turner AL, Braine EL, Pobjoy J, Lenzo JC, Hamilton JA.
Arthritis Rheum. 2011 Aug;63(8):2340-51. doi: 10.1002/art.30354.
Novel lymphocyte-independent mechanisms to initiate inflammatory arthritis via bone marrow-derived cells of Ali18 mutant mice.
Abe K, Wechs S, Kalaydjiev S, Franz TJ, Busch DH, Fuchs H, Soewarto D, Behrendt H, Wagner S, Jakob T, Hrabé de Angelis M.
Rheumatology (Oxford). 2008 Mar;47(3):292-300.
Bone matrix degradation by the plasminogen activation system. Possible mechanism of bone destruction in arthritis.
Ronday HK, Smits HH, Quax PH, van der Pluijm G, Löwik CW, Breedveld FC, Verheijen JH.
Br J Rheumatol. 1997 Jan;36(1):9-15.
The adaptor protein CIKS/ACT1 is necessary for collagen-induced arthritis, and it contributes to the production of collagen-specific antibody.
Pisitkun P, Claudio E, Ren N, Wang H, Siebenlist U.
Arthritis Rheum. 2010 Nov;62(11):3334-44. doi: 10.1002/art.27653.
Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models.
Li J, Guo Y, Holmdahl R, Ny T.
Arthritis Rheum. 2005 Aug;52(8):2541-8.
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
The inhibitory co-receptor, PECAM-1 provides a protective effect in suppression of collagen-induced arthritis.
Wong MX, Hayball JD, Hogarth PM, Jackson DE.
J Clin Immunol. 2005 Jan;25(1):19-28.
Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice.
Ahn MY, Zhang ZG, Tsang W, Chopp M.
Brain Res. 1999 Aug 7;837(1-2):169-76.
Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, van den Berg WB.
Arthritis Rheum. 2004 Feb;50(2):650-9.
Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation.
Brommer EJ, Dooijewaard G, Dijkmans BA, Breedveld FC.
Thromb Haemost. 1992 Aug 3;68(2):180-4.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on